HL7 Europe Laboratory Report, published by HL7 Europe. This guide is not an authorized publication; it is the continuous build for version 0.2.0-ci built by the FHIR (HL7® FHIR® Standard) CI Build. This version is based on the current content of https://github.com/hl7-eu/laboratory/ and changes regularly. See the Directory of published versions
Page standards status: Draft | Maturity Level: 1 |
@prefix fhir: <http://hl7.org/fhir/> . @prefix owl: <http://www.w3.org/2002/07/owl#> . @prefix rdfs: <http://www.w3.org/2000/01/rdf-schema#> . @prefix xsd: <http://www.w3.org/2001/XMLSchema#> . # - resource ------------------------------------------------------------------- a fhir:ValueSet ; fhir:nodeRole fhir:treeRoot ; fhir:id [ fhir:v "lab-certifiedRefMaterial-eu-lab"] ; # fhir:text [ fhir:status [ fhir:v "generated" ] ; fhir:div "<div xmlns=\"http://www.w3.org/1999/xhtml\"><p class=\"res-header-id\"><b>Generated Narrative: ValueSet lab-certifiedRefMaterial-eu-lab</b></p><a name=\"lab-certifiedRefMaterial-eu-lab\"> </a><a name=\"hclab-certifiedRefMaterial-eu-lab\"> </a><a name=\"lab-certifiedRefMaterial-eu-lab-en-US\"> </a><p>This value set includes codes based on the following rules:</p><ul><li>Include these codes as defined in <code>http://nibsc.org</code><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>06/140</td><td>Pertussis antiserum (human), anti-PT IgG, Lyophilized, 335 IU and anti-PT IgA 65 IU / ampoule; anti-FHA IgG 130 IU and anti-FHA IgA 65 IU / ampoule; anti-69K IgG 65 IU and anti-PT IgA 42 IU / ampoule</td></tr><tr><td>00/588</td><td>Hepatitis B virus surface antigen, subtype adw2, genotype A, Lyophilized, 33 IU/vial.</td></tr><tr><td>01/600</td><td>Anti-toxoplasma serum (IgG), Lyophilized, 20 IU / ampoule.</td></tr><tr><td>01/608</td><td>Low Molecular Weight Heparin</td></tr><tr><td>02/150</td><td>Blood Coagulation Factor VIII and Von Willebrand Factor in Plasma, Human</td></tr><tr><td>02/206</td><td>Blood coagulation factor XIII, Lyophilized, Activity 0.91 IU/ampoule; Antigen 0.93 IU/ampoule</td></tr><tr><td>02/342</td><td>Protein C, Lyophilized, 0.85 IU/ampoule (function), 0.84 IU/ampoule (antigen).</td></tr><tr><td>03/116</td><td>Blood coagulation factor V, Lyophilized, 0.74 IU of Factor V:C per ampoule</td></tr><tr><td>03/228</td><td>Protein S, Lyophilized, 0.83 IU/ampoule (total antigen), 0.81 IU/ampoule (free antigen), 0.77 IU/ampoule (function).</td></tr><tr><td>04/102</td><td>Blood coagulation factor XI, plasma human, Lyophilized., 0.86 International Units per ampoule</td></tr><tr><td>07/164</td><td>Anti-hepatitis B immunoglobulin, Lyophilized, 100 IU/ampoule</td></tr><tr><td>07/316</td><td>Blood coagulation factor VIII and von Willebrand factor, Lyophilized, Factor VIII: C 0.68 IU/ amp; Factor VIII:Antigen 1.04 IU/ amp; VWF:Antigen 1.00 IU/ amp; VWF:Ristocetin cofactor 0.87 IU/amp; VWF:Collagen binding 1.03 IU/amp; VWFpp 1.03 IU/amp</td></tr><tr><td>07/364</td><td>Chorionic gonadotrophin, Lyophilized 179 International Units or 0.39 nmol per ampoule for calibration of immunossays, and 162 International Units per ampoule for calibration of biossay, ,</td></tr><tr><td>08/204</td><td>Thyroid-stimulating antibody, Lyophilized, 0.113 IU / ampoule.</td></tr><tr><td>08/258</td><td>Antithrombin, Lyophilized, Functional potency - 0.95 IU/ampoule, Antigenic potency - 0.96 IU/ampoule</td></tr><tr><td>08/266</td><td>Sex hormone binding globulin (SHBG), Lyophilized, 180 IU / ampoule.</td></tr><tr><td>09/162</td><td>Human cytomegalovirus DNA, Lyophilized, 5,000,000 IU/vial.</td></tr><tr><td>09/172</td><td>Blood coagulation factors II, VII, IX, X, Lyophilized, 0.89 IU (factor II), 0.99 IU (factor VII), 0.9 IU (factor IX), 0.89 IU (factor X) / ampoule.</td></tr><tr><td>09/260</td><td>Epstein Barr virus DNA, Lyophilized, 5,000,000 IU/ml</td></tr><tr><td>09/264</td><td>Fibrinogen, Lyophilized, 2.7 mg/ampoule</td></tr><tr><td>10/152</td><td>HIV-1 RNA, Lyophilized, 185,000 IU/ml (5.27 log10 IU/ml)</td></tr><tr><td>10/262</td><td>Diphtheria Antitoxin Human IgG, Lyophilized, 2 IU / ampoule</td></tr><tr><td>10/264</td><td>Hepatitis B virus DNA, Lyophilized., 850,000 IU / vial.</td></tr><tr><td>11/176</td><td>Heparin, low molecular weight, Lyophilized, Anti-Xa: 1068 IU/ampoule, Anti-Iia: 342 IU/ampoule</td></tr><tr><td>11/234</td><td>Human serum immunoglobulin E, Lyophilized, 13,500 IU/mL</td></tr><tr><td>11/700</td><td>Erythropoietin, rDNA-derived, Lyophilized, 1,650 IU / ampoule.</td></tr><tr><td>12/252</td><td>A Disintegrin And Metalloprotease with ThromboSpondin type 1 motifs 13 (ADAMTS13), plasma, Lyophilized., Function: 0.91 IU/ampoule Antigen: 0.92 IU/ampoule</td></tr><tr><td>14/114</td><td>JC polyomavirus DNA, Lyophilized., 7.0 log10 IU/ mL</td></tr><tr><td>14/212</td><td>BK polyomavirus DNA, Lyophilized., 7.2 log10 IU/ mL</td></tr><tr><td>15/180</td><td>Factor XI, plasma, human, Lyophilized, Functional activity: 0.71 IU per ampoule, Antigen: 0.78 IU per ampoule</td></tr><tr><td>16/368</td><td>HSV-1</td></tr><tr><td>17/100</td><td>Prostate Specific Antigen (human)(total: PSA-ACT + free PSA)</td></tr><tr><td>17/122</td><td>HSV-2</td></tr><tr><td>66/304</td><td>Insulin, human, for immunoassay, Lyophilized, 3 IU / ampoule.</td></tr><tr><td>67/086</td><td>Human serum immunoglobulins G, A, and M (IgG, IgA and IgM), Lyophilized, 100 IU IgG, 100 IU IgA and 100 IU IgM/ampoule.</td></tr><tr><td>67/343</td><td>Erythropoietin, human, urinary, Lyophilized, 10 IU / ampoule.</td></tr><tr><td>68/356</td><td>Renin, human, Lyophilized, 0.1 IU / ampoule.</td></tr><tr><td>69/194</td><td>Glucagon, porcine, Lyophilized, 1.49 IU / ampoule.</td></tr><tr><td>73/545</td><td>Placental lactogen, human, for immunoassay, Lyophilized, 0.000 850 IU / ampoule.</td></tr><tr><td>73/601</td><td>Carcinoembryonic antigen (CEA), Lyophilized, 100 IU/ampoule</td></tr><tr><td>75/551</td><td>Chorionic gonadotrophin, beta subunit, human, for immunoassay, Lyophilized, 70 IU / ampoule.</td></tr><tr><td>75/569</td><td>Chorionic gonadotrophin, alpha subunit, human, for immunoassay, Lyophilized, 70 IU / ampoule.</td></tr><tr><td>75/589</td><td>Chorionic gonadotrophin, human, Lyophilized, 650 IU / ampoule.</td></tr><tr><td>78/554</td><td>Luteinizing hormone, human, pituitary, alpha subunit, Lyophilized, 10 IU / ampoule.</td></tr><tr><td>78/556</td><td>Luteinizing hormone, human, pituitary, beta subunit, Lyophilized, 10 IU / ampoule.</td></tr><tr><td>79/500</td><td>Parathyroid hormone, human, for immunoassay, Lyophilized, 0.1 IU / ampoule.</td></tr><tr><td>80/505</td><td>Human growth hormone, pituitary, Lyophilized, 4.4 IU / ampoule.</td></tr><tr><td>80/552</td><td>Luteinizing hormone, human, pituitary, Lyophilized, 35 IU / ampoule.</td></tr><tr><td>81/565</td><td>Thyroid stimulating hormone, human, for immunoassay, Lyophilized, 11.5 x -3 log 10 IU / ampoule.</td></tr><tr><td>82/585</td><td>Anti-poliovirus serum (Types 1, 2, 3), Lyophilized, 11 IU/ampoule (Type 1), 32 IU/ampoule (Type 2), 3 IU/ampoule (Type 3)</td></tr><tr><td>82/587</td><td>Interferon Gamma (Human, Leukocyte derived)</td></tr><tr><td>83/501</td><td>Beta-thromboglobulin, Lyophilized, 500 IU/ampoule.</td></tr><tr><td>83/505</td><td>Platelet factor 4, Lyophilized, 400 IU/ampoule</td></tr><tr><td>83/575</td><td>Follicle stimulating hormone, human, pituitary, Lyophilized, 80 IU / ampoule.</td></tr><tr><td>84/500</td><td>Prolactin, human, Lyophilized., 0.053 IU / ampoule.</td></tr><tr><td>85/506</td><td>C-reactive protein, Lyophilized, 0.049 IU/ampoule</td></tr><tr><td>85/669</td><td>Atrial natriuretic factor, human, Lyophilized, 2.5 IU / ampoule.</td></tr><tr><td>88/638</td><td>Thyroxine-binding globulin, Lyophilized, 30 IU / ampoule.</td></tr><tr><td>89/620</td><td>Calcitonin, human, Lyophilized, 17.5 IU / ampoule.</td></tr><tr><td>91/554</td><td>Insulin-like growth factor I for bioassay, Lyophilized, 150 IU / ampoule.</td></tr><tr><td>91/624</td><td>Inhibin A, human, recombinant, Lyophilized, 150,000 IU / ampoule.</td></tr><tr><td>92/510</td><td>Follicle stimulating hormone, human, recombinant for immunoassay, Lyophilized, 60 IU / ampoule.</td></tr><tr><td>92/654</td><td>Plasminogen-Activator Inhibitor 1 (PAI-1), Lyophilized, Tissueplasminogen-activator: 27.5 IU of neutralising activity/ampoule. Urinary-plasminogen-activator: 7 IU of neutralising activity/ampoule.</td></tr><tr><td>94/572</td><td>Ferritin, recombinant, Lyophilized, 6.3 μg/ampoule</td></tr><tr><td>96/670</td><td>Prostate specific antigen (90:10), Lyophilized, 1 μg total PSA per vial.</td></tr><tr><td>97/550</td><td>Islet cell antibodies, Lyophilized, 20 units/ampoule of islet cell antibodies; 100 units/ampoule of anti-GAD65; 100 units/ampoule of anti-IA-2.</td></tr><tr><td>97/646</td><td>Anti-Hepatitis A Immunoglobulin, Human (W1041) WHO International Standard</td></tr><tr><td>98/574</td><td>Somatropin (rDNA-derived human growth hormone), Lyophilized, 1.95 mg protein / ampoule.</td></tr><tr><td>AFP</td><td>Alphafoetoprotein, Lyophilized, 100,000 IU / ampoule.</td></tr><tr><td>RAI</td><td>Anti-rabies immunoglobulin, Lyophilized, 30 IU/ampoule</td></tr><tr><td>rTF/16</td><td>Thromboplastin, Human, Recombinant, Plain 5th International Standard 2016.</td></tr><tr><td>RUBI-1-94</td><td>Anti-rubella immunoglobulin, Lyophilized, 1,600 IU/vial</td></tr><tr><td>W1066</td><td>Rheumatoid arthritis serum, Lyophilized, 100 IU/ampoule</td></tr></table></li><li>Include these codes as defined in <code>http://pei.de</code><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>7657/12</td><td>Hepatitis D virus RNA, Lyophilized, 575,000 IU/mL</td></tr></table></li><li>Include these codes as defined in <code>http://niaid.nih.gov</code><table class=\"none\"><tr><td style=\"white-space:nowrap\"><b>Code</b></td><td><b>Display</b></td></tr><tr><td>Gxg01-902535</td><td>Interferon gamma, human, recombinant, Lyophilized, 80,000 IU / ampoule.</td></tr></table></li></ul></div>" ] ; # fhir:extension ( [ fhir:url [ fhir:v "http://hl7.org/fhir/StructureDefinition/structuredefinition-fmm"^^xsd:anyURI ] ; fhir:value [ fhir:v "1"^^xsd:integer ] ] [ fhir:url [ fhir:v "http://hl7.org/fhir/StructureDefinition/structuredefinition-standards-status"^^xsd:anyURI ] ; fhir:value [ fhir:v "draft" ] ] ) ; # fhir:url [ fhir:v "http://hl7.eu/fhir/laboratory/ValueSet/lab-certifiedRefMaterial-eu-lab"^^xsd:anyURI] ; # fhir:version [ fhir:v "0.2.0-ci"] ; # fhir:name [ fhir:v "LabCertifiedReferenceMaterialVS"] ; # fhir:title [ fhir:v "Laboratory Certified Reference Material"] ; # fhir:status [ fhir:v "draft"] ; # fhir:experimental [ fhir:v "true"^^xsd:boolean] ; # fhir:date [ fhir:v "2024-12-14T06:50:57+00:00"^^xsd:dateTime] ; # fhir:publisher [ fhir:v "HL7 Europe"] ; # fhir:contact ( [ fhir:name [ fhir:v "HL7 Europe" ] ; ( fhir:telecom [ fhir:system [ fhir:v "url" ] ; fhir:value [ fhir:v "http://hl7.eu" ] ] ) ] ) ; # fhir:description [ fhir:v "List of the coded concepts describing the certified reference material used for the calibration, typically used when the unit of the result is UCUM [IU]."] ; # fhir:jurisdiction ( [ ( fhir:coding [ fhir:system [ fhir:v "http://unstats.un.org/unsd/methods/m49/m49.htm"^^xsd:anyURI ] ; fhir:code [ fhir:v "150" ] ; fhir:display [ fhir:v "Europe" ] ] ) ] ) ; # fhir:copyright [ fhir:v "This material contains content from the NIBSC Product list (https://nibsc.org/NIBSC%20Product%20List%20-%20Feb%2024.pdf). The National Institute for Biological Standards and Control part of the UK Medicines and Healthcare products Regulatory Agency (MHRA)."] ; # fhir:compose [ ( fhir:include [ fhir:system [ fhir:v "http://nibsc.org"^^xsd:anyURI ] ; ( fhir:concept [ fhir:code [ fhir:v "06/140" ] ; fhir:display [ fhir:v "Pertussis antiserum (human), anti-PT IgG, Lyophilized, 335 IU and anti-PT IgA 65 IU / ampoule; anti-FHA IgG 130 IU and anti-FHA IgA 65 IU / ampoule; anti-69K IgG 65 IU and anti-PT IgA 42 IU / ampoule" ] ] [ fhir:code [ fhir:v "00/588" ] ; fhir:display [ fhir:v "Hepatitis B virus surface antigen, subtype adw2, genotype A, Lyophilized, 33 IU/vial." ] ] [ fhir:code [ fhir:v "01/600" ] ; fhir:display [ fhir:v "Anti-toxoplasma serum (IgG), Lyophilized, 20 IU / ampoule." ] ] [ fhir:code [ fhir:v "01/608" ] ; fhir:display [ fhir:v "Low Molecular Weight Heparin" ] ] [ fhir:code [ fhir:v "02/150" ] ; fhir:display [ fhir:v "Blood Coagulation Factor VIII and Von Willebrand Factor in Plasma, Human" ] ] [ fhir:code [ fhir:v "02/206" ] ; fhir:display [ fhir:v "Blood coagulation factor XIII, Lyophilized, Activity 0.91 IU/ampoule; Antigen 0.93 IU/ampoule" ] ] [ fhir:code [ fhir:v "02/342" ] ; fhir:display [ fhir:v "Protein C, Lyophilized, 0.85 IU/ampoule (function), 0.84 IU/ampoule (antigen)." ] ] [ fhir:code [ fhir:v "03/116" ] ; fhir:display [ fhir:v "Blood coagulation factor V, Lyophilized, 0.74 IU of Factor V:C per ampoule" ] ] [ fhir:code [ fhir:v "03/228" ] ; fhir:display [ fhir:v "Protein S, Lyophilized, 0.83 IU/ampoule (total antigen), 0.81 IU/ampoule (free antigen), 0.77 IU/ampoule (function)." ] ] [ fhir:code [ fhir:v "04/102" ] ; fhir:display [ fhir:v "Blood coagulation factor XI, plasma human, Lyophilized., 0.86 International Units per ampoule" ] ] [ fhir:code [ fhir:v "07/164" ] ; fhir:display [ fhir:v "Anti-hepatitis B immunoglobulin, Lyophilized, 100 IU/ampoule" ] ] [ fhir:code [ fhir:v "07/316" ] ; fhir:display [ fhir:v "Blood coagulation factor VIII and von Willebrand factor, Lyophilized, Factor VIII: C 0.68 IU/ amp; Factor VIII:Antigen 1.04 IU/ amp; VWF:Antigen 1.00 IU/ amp; VWF:Ristocetin cofactor 0.87 IU/amp; VWF:Collagen binding 1.03 IU/amp; VWFpp 1.03 IU/amp" ] ] [ fhir:code [ fhir:v "07/364" ] ; fhir:display [ fhir:v "Chorionic gonadotrophin, Lyophilized 179 International Units or 0.39 nmol per ampoule for calibration of immunossays, and 162 International Units per ampoule for calibration of biossay, ," ] ] [ fhir:code [ fhir:v "08/204" ] ; fhir:display [ fhir:v "Thyroid-stimulating antibody, Lyophilized, 0.113 IU / ampoule." ] ] [ fhir:code [ fhir:v "08/258" ] ; fhir:display [ fhir:v "Antithrombin, Lyophilized, Functional potency - 0.95 IU/ampoule, Antigenic potency - 0.96 IU/ampoule" ] ] [ fhir:code [ fhir:v "08/266" ] ; fhir:display [ fhir:v "Sex hormone binding globulin (SHBG), Lyophilized, 180 IU / ampoule." ] ] [ fhir:code [ fhir:v "09/162" ] ; fhir:display [ fhir:v "Human cytomegalovirus DNA, Lyophilized, 5,000,000 IU/vial." ] ] [ fhir:code [ fhir:v "09/172" ] ; fhir:display [ fhir:v "Blood coagulation factors II, VII, IX, X, Lyophilized, 0.89 IU (factor II), 0.99 IU (factor VII), 0.9 IU (factor IX), 0.89 IU (factor X) / ampoule." ] ] [ fhir:code [ fhir:v "09/260" ] ; fhir:display [ fhir:v "Epstein Barr virus DNA, Lyophilized, 5,000,000 IU/ml" ] ] [ fhir:code [ fhir:v "09/264" ] ; fhir:display [ fhir:v "Fibrinogen, Lyophilized, 2.7 mg/ampoule" ] ] [ fhir:code [ fhir:v "10/152" ] ; fhir:display [ fhir:v "HIV-1 RNA, Lyophilized, 185,000 IU/ml (5.27 log10 IU/ml)" ] ] [ fhir:code [ fhir:v "10/262" ] ; fhir:display [ fhir:v "Diphtheria Antitoxin Human IgG, Lyophilized, 2 IU / ampoule" ] ] [ fhir:code [ fhir:v "10/264" ] ; fhir:display [ fhir:v "Hepatitis B virus DNA, Lyophilized., 850,000 IU / vial." ] ] [ fhir:code [ fhir:v "11/176" ] ; fhir:display [ fhir:v "Heparin, low molecular weight, Lyophilized, Anti-Xa: 1068 IU/ampoule, Anti-Iia: 342 IU/ampoule" ] ] [ fhir:code [ fhir:v "11/234" ] ; fhir:display [ fhir:v "Human serum immunoglobulin E, Lyophilized, 13,500 IU/mL" ] ] [ fhir:code [ fhir:v "11/700" ] ; fhir:display [ fhir:v "Erythropoietin, rDNA-derived, Lyophilized, 1,650 IU / ampoule." ] ] [ fhir:code [ fhir:v "12/252" ] ; fhir:display [ fhir:v "A Disintegrin And Metalloprotease with ThromboSpondin type 1 motifs 13 (ADAMTS13), plasma, Lyophilized., Function: 0.91 IU/ampoule Antigen: 0.92 IU/ampoule" ] ] [ fhir:code [ fhir:v "14/114" ] ; fhir:display [ fhir:v "JC polyomavirus DNA, Lyophilized., 7.0 log10 IU/ mL" ] ] [ fhir:code [ fhir:v "14/212" ] ; fhir:display [ fhir:v "BK polyomavirus DNA, Lyophilized., 7.2 log10 IU/ mL" ] ] [ fhir:code [ fhir:v "15/180" ] ; fhir:display [ fhir:v "Factor XI, plasma, human, Lyophilized, Functional activity: 0.71 IU per ampoule, Antigen: 0.78 IU per ampoule" ] ] [ fhir:code [ fhir:v "16/368" ] ; fhir:display [ fhir:v "HSV-1" ] ] [ fhir:code [ fhir:v "17/100" ] ; fhir:display [ fhir:v "Prostate Specific Antigen (human)(total: PSA-ACT + free PSA)" ] ] [ fhir:code [ fhir:v "17/122" ] ; fhir:display [ fhir:v "HSV-2" ] ] [ fhir:code [ fhir:v "66/304" ] ; fhir:display [ fhir:v "Insulin, human, for immunoassay, Lyophilized, 3 IU / ampoule." ] ] [ fhir:code [ fhir:v "67/086" ] ; fhir:display [ fhir:v "Human serum immunoglobulins G, A, and M (IgG, IgA and IgM), Lyophilized, 100 IU IgG, 100 IU IgA and 100 IU IgM/ampoule." ] ] [ fhir:code [ fhir:v "67/343" ] ; fhir:display [ fhir:v "Erythropoietin, human, urinary, Lyophilized, 10 IU / ampoule." ] ] [ fhir:code [ fhir:v "68/356" ] ; fhir:display [ fhir:v "Renin, human, Lyophilized, 0.1 IU / ampoule." ] ] [ fhir:code [ fhir:v "69/194" ] ; fhir:display [ fhir:v "Glucagon, porcine, Lyophilized, 1.49 IU / ampoule." ] ] [ fhir:code [ fhir:v "73/545" ] ; fhir:display [ fhir:v "Placental lactogen, human, for immunoassay, Lyophilized, 0.000 850 IU / ampoule." ] ] [ fhir:code [ fhir:v "73/601" ] ; fhir:display [ fhir:v "Carcinoembryonic antigen (CEA), Lyophilized, 100 IU/ampoule" ] ] [ fhir:code [ fhir:v "75/551" ] ; fhir:display [ fhir:v "Chorionic gonadotrophin, beta subunit, human, for immunoassay, Lyophilized, 70 IU / ampoule." ] ] [ fhir:code [ fhir:v "75/569" ] ; fhir:display [ fhir:v "Chorionic gonadotrophin, alpha subunit, human, for immunoassay, Lyophilized, 70 IU / ampoule." ] ] [ fhir:code [ fhir:v "75/589" ] ; fhir:display [ fhir:v "Chorionic gonadotrophin, human, Lyophilized, 650 IU / ampoule." ] ] [ fhir:code [ fhir:v "78/554" ] ; fhir:display [ fhir:v "Luteinizing hormone, human, pituitary, alpha subunit, Lyophilized, 10 IU / ampoule." ] ] [ fhir:code [ fhir:v "78/556" ] ; fhir:display [ fhir:v "Luteinizing hormone, human, pituitary, beta subunit, Lyophilized, 10 IU / ampoule." ] ] [ fhir:code [ fhir:v "79/500" ] ; fhir:display [ fhir:v "Parathyroid hormone, human, for immunoassay, Lyophilized, 0.1 IU / ampoule." ] ] [ fhir:code [ fhir:v "80/505" ] ; fhir:display [ fhir:v "Human growth hormone, pituitary, Lyophilized, 4.4 IU / ampoule." ] ] [ fhir:code [ fhir:v "80/552" ] ; fhir:display [ fhir:v "Luteinizing hormone, human, pituitary, Lyophilized, 35 IU / ampoule." ] ] [ fhir:code [ fhir:v "81/565" ] ; fhir:display [ fhir:v "Thyroid stimulating hormone, human, for immunoassay, Lyophilized, 11.5 x -3 log 10 IU / ampoule." ] ] [ fhir:code [ fhir:v "82/585" ] ; fhir:display [ fhir:v "Anti-poliovirus serum (Types 1, 2, 3), Lyophilized, 11 IU/ampoule (Type 1), 32 IU/ampoule (Type 2), 3 IU/ampoule (Type 3)" ] ] [ fhir:code [ fhir:v "82/587" ] ; fhir:display [ fhir:v "Interferon Gamma (Human, Leukocyte derived)" ] ] [ fhir:code [ fhir:v "83/501" ] ; fhir:display [ fhir:v "Beta-thromboglobulin, Lyophilized, 500 IU/ampoule." ] ] [ fhir:code [ fhir:v "83/505" ] ; fhir:display [ fhir:v "Platelet factor 4, Lyophilized, 400 IU/ampoule" ] ] [ fhir:code [ fhir:v "83/575" ] ; fhir:display [ fhir:v "Follicle stimulating hormone, human, pituitary, Lyophilized, 80 IU / ampoule." ] ] [ fhir:code [ fhir:v "84/500" ] ; fhir:display [ fhir:v "Prolactin, human, Lyophilized., 0.053 IU / ampoule." ] ] [ fhir:code [ fhir:v "85/506" ] ; fhir:display [ fhir:v "C-reactive protein, Lyophilized, 0.049 IU/ampoule" ] ] [ fhir:code [ fhir:v "85/669" ] ; fhir:display [ fhir:v "Atrial natriuretic factor, human, Lyophilized, 2.5 IU / ampoule." ] ] [ fhir:code [ fhir:v "88/638" ] ; fhir:display [ fhir:v "Thyroxine-binding globulin, Lyophilized, 30 IU / ampoule." ] ] [ fhir:code [ fhir:v "89/620" ] ; fhir:display [ fhir:v "Calcitonin, human, Lyophilized, 17.5 IU / ampoule." ] ] [ fhir:code [ fhir:v "91/554" ] ; fhir:display [ fhir:v "Insulin-like growth factor I for bioassay, Lyophilized, 150 IU / ampoule." ] ] [ fhir:code [ fhir:v "91/624" ] ; fhir:display [ fhir:v "Inhibin A, human, recombinant, Lyophilized, 150,000 IU / ampoule." ] ] [ fhir:code [ fhir:v "92/510" ] ; fhir:display [ fhir:v "Follicle stimulating hormone, human, recombinant for immunoassay, Lyophilized, 60 IU / ampoule." ] ] [ fhir:code [ fhir:v "92/654" ] ; fhir:display [ fhir:v "Plasminogen-Activator Inhibitor 1 (PAI-1), Lyophilized, Tissueplasminogen-activator: 27.5 IU of neutralising activity/ampoule. Urinary-plasminogen-activator: 7 IU of neutralising activity/ampoule." ] ] [ fhir:code [ fhir:v "94/572" ] ; fhir:display [ fhir:v "Ferritin, recombinant, Lyophilized, 6.3 μg/ampoule" ] ] [ fhir:code [ fhir:v "96/670" ] ; fhir:display [ fhir:v "Prostate specific antigen (90:10), Lyophilized, 1 μg total PSA per vial." ] ] [ fhir:code [ fhir:v "97/550" ] ; fhir:display [ fhir:v "Islet cell antibodies, Lyophilized, 20 units/ampoule of islet cell antibodies; 100 units/ampoule of anti-GAD65; 100 units/ampoule of anti-IA-2." ] ] [ fhir:code [ fhir:v "97/646" ] ; fhir:display [ fhir:v "Anti-Hepatitis A Immunoglobulin, Human (W1041) WHO International Standard" ] ] [ fhir:code [ fhir:v "98/574" ] ; fhir:display [ fhir:v "Somatropin (rDNA-derived human growth hormone), Lyophilized, 1.95 mg protein / ampoule." ] ] [ fhir:code [ fhir:v "AFP" ] ; fhir:display [ fhir:v "Alphafoetoprotein, Lyophilized, 100,000 IU / ampoule." ] ] [ fhir:code [ fhir:v "RAI" ] ; fhir:display [ fhir:v "Anti-rabies immunoglobulin, Lyophilized, 30 IU/ampoule" ] ] [ fhir:code [ fhir:v "rTF/16" ] ; fhir:display [ fhir:v "Thromboplastin, Human, Recombinant, Plain 5th International Standard 2016." ] ] [ fhir:code [ fhir:v "RUBI-1-94" ] ; fhir:display [ fhir:v "Anti-rubella immunoglobulin, Lyophilized, 1,600 IU/vial" ] ] [ fhir:code [ fhir:v "W1066" ] ; fhir:display [ fhir:v "Rheumatoid arthritis serum, Lyophilized, 100 IU/ampoule" ] ] ) ] [ fhir:system [ fhir:v "http://pei.de"^^xsd:anyURI ] ; ( fhir:concept [ fhir:code [ fhir:v "7657/12" ] ; fhir:display [ fhir:v "Hepatitis D virus RNA, Lyophilized, 575,000 IU/mL" ] ] ) ] [ fhir:system [ fhir:v "http://niaid.nih.gov"^^xsd:anyURI ] ; ( fhir:concept [ fhir:code [ fhir:v "Gxg01-902535" ] ; fhir:display [ fhir:v "Interferon gamma, human, recombinant, Lyophilized, 80,000 IU / ampoule." ] ] ) ] ) ] . #
IG © 2023+ HL7 Europe. Package hl7.fhir.eu.laboratory#0.2.0-ci based on FHIR 4.0.1. Generated 2024-12-14